BF
PACB icon

BOK Financial’s Pacific Biosciences PACB Stock Holding History

BOK Financial’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-90,145
Closed -$276K – 879
2020
Q1 		$276K Sell
90,145
-200,000
-69% -$819K 0.01% 710
2019
Q4 		$1.49M Buy
290,145
+17,621
+6% +$89.6K 0.03% 418
2019
Q3 		$1.41M Sell
272,524
-2,978
-1% -$16.7K 0.03% 426
2019
Q2 		$1.67M Buy
275,502
+135,411
+97% +$950K 0.04% 370
2019
Q1 		$1.01M Buy
140,091
+94,719
+209% +$685K 0.02% 480
2018
Q4 		$335K Buy
+45,372
New +$287K 0.01% 714

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
WIC
Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KLCMU
Kite Lake Capital Management (UK) London, United Kingdom $290M AUM 183.72% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

BOK Financial's PACB Position: Q2 2020 in Review

BOK Financial sold out of Pacific Biosciences (PACB) in Q2 2020, closing a stake of 90,145 shares — an estimated $276K sold.

BOK Financial first reported a position in PACB in Q4 2018 and held it in 6 quarters. The position peaked at $1.67M in Q2 2019. 151 funds tracked by Wall St. Rank hold PACB as of Q2 2020.

  • BOK Financial reported no remaining Pacific Biosciences position as of Q2 2020 after selling out during the quarter.
  • BOK Financial sold 90,145 Pacific Biosciences shares in Q2 2020, an estimated $276K.
  • BOK Financial first reported a position in Pacific Biosciences in Q4 2018 and held it in 6 quarters.
  • BOK Financial's Pacific Biosciences position peaked at $1.67M in Q2 2019.
  • 151 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2020.

Based on BOK Financial's 13F filing for Q2 2020, filed 12 Aug 2020.